Fumitory (Fumaria officinalis)

Quick Summary

Fumaria officinalis, commonly known as Fumitory, is a medicinal herb primarily investigated for gastrointestinal uses including irritable bowel syndrome (IBS). Current clinical evidence does not support significant clinical benefit of Fumitory extracts for IBS symptom improvement. Traditional uses include treatment of digestive and skin disorders, but rigorous human clinical data are limited, and clinical efficacy remains unproven.

What is it?

Fumitory (Fumaria officinalis) is a flowering herb traditionally used in various systems of herbal medicine. It is known for its historical application in digestive health and skin disorders. Despite longstanding use, scientific investigation into its effects remains limited.

Traditional Uses

• Management of digestive discomfort and support of gastrointestinal function.
• Treatment of skin-related problems and wound healing.
• Relief of symptoms associated with irritable bowel syndrome (IBS).

Active Compounds

The herb contains a variety of alkaloids and other phytochemicals believed to contribute to its traditional medicinal effects. Specific active constituents responsible for therapeutic activity have not been fully characterized in clinical contexts.

Potential Benefits with Evidence Levels

• Irritable Bowel Syndrome (IBS) Symptom Management – Insufficient evidence: Clinical reviews and systematic analyses indicate that Fumaria officinalis has not demonstrated significant clinical benefit in IBS treatment. Evidence from human trials is lacking or negative.
• Traditional Use in Skin-Related Problems and Wound Healing – Traditional/preclinical evidence only: Ethnobotanical data report Fumaria officinalis use in traditional medicine for skin ailments, but there is no robust clinical evidence for efficacy.
• Gastrointestinal Support (General Digestive Discomfort) – Traditional use, no clinical confirmation: Historical and traditional sources cite Fumitory for digestive complaints, but clinical trials have not substantiated these effects.

Side Effects

No serious adverse effects specifically attributed to Fumaria officinalis were reported in the consulted literature. Well-documented or significant adverse effects are lacking, but spontaneous reports and toxicology data are limited. Overall safety profiles remain insufficiently characterized in controlled human studies.

Drug Interactions

No specific drug interactions with Fumaria officinalis have been reported in the available literature. The herb has not been studied extensively for interactions involving cytochrome P450 enzymes or other pharmacokinetic mechanisms.

Who Should Avoid It?

Due to a lack of clinical safety data, especially during pregnancy and breastfeeding, caution is advised for these populations. No explicit contraindications have been described in current clinical or systematic review data. Individuals with known allergies to related plants should exercise caution.

Evidence Limitations

Clinical evidence on Fumaria officinalis is limited by the scarcity of high-quality randomized controlled trials, small sample sizes, and inadequate methodological rigor. Most data derive from traditional use, preclinical studies, or comparative herbal reviews rather than robust clinical trials. Reported negative or inconclusive findings further limit support for therapeutic claims.

References

• Pastras P, Aggeletopoulou I, Bali M, Triantos C. (2026). Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines. Systematic reviews indicate no significant clinical benefit for Fumaria officinalis in IBS treatment.
• Rahimi R, Abdollahi M. (2012). Herbal medicines for the management of irritable bowel syndrome: A comprehensive review. Some herbal medicines may improve IBS symptoms, but Fumaria officinalis did not demonstrate benefit.
• Fifi AC, Axelrod CH, Chakraborty P, Saps M. (2018). Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials. Data on many herbs are limited; no firm efficacy conclusions for Fumaria officinalis.
• Tsioutsiou EE et al. (2022). Medicinal Plants Used Traditionally for Skin Related Problems in the South Balkan and East Mediterranean Region-A Review. Traditional ethnobotanical uses include skin ailments though clinical evidence is lacking.
• Allkanjari O et al. (2022). A descriptive study of commercial herbal dietary supplements used for dyslipidemia-Sales data and suspected adverse reactions. Discussion of herbal supplement safety and adverse reactions, though Fumaria officinalis specific data are lacking.

Last Reviewed

June 2024

Disclaimer

This information is provided for educational purposes only and is not intended as medical advice. The evidence base for Fumaria officinalis is limited and inconclusive. Consult a healthcare professional before using herbal supplements, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking medications.